by Elena Iemma | Jun 16, 2022
Novel H7N9 influenza immunogen design enhances mobilization of seasonal influenza T cell memory in H3N2 pre-immune mice
by Elena Iemma | Jun 7, 2022
A novel SARS-CoV-2 T cell targeting, peptide-based vaccine candidate designed using the iVAX platform
by Elena Iemma | Sep 13, 2021
Novel immunogen design elicits increased protection against avian H7N9 influenza that is associated with mobilization of seasonal influenza T cell memory
by Elena Iemma | Sep 10, 2021
Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation